Neutralizing antibodies for the treatment of COVID-19
Neutralizing antibodies for the treatment of COVID-19
About this item
Full title
Neutralizing antibodies for the treatment of COVID-19
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature biomedical engineering, 2020-12, Vol.4 (12), p.1134-1139
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
More clinical trial data are needed to determine whether sera from COVID-19-convalescent patients and neutralizing monoclonal antibodies specific to SARS-CoV-2 antigens can prevent COVID-19 or reduce the severity of the disease in high-risk populations.
Alternative Titles
Full title
Neutralizing antibodies for the treatment of COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7891858
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7891858
Other Identifiers
ISSN
2157-846X
E-ISSN
2157-846X
DOI
10.1038/s41551-020-00660-2
